Investing in Innovation (i3) announces its first cohort of 30 African startups
Investing in Innovation (i3), a pan-African support initiative for African health supply chain start-ups, has announced its first cohort
Source: kachwanya.com
📰 Merck Sharp News
Page 58 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
Medicenna Reports Confirmed Partial Response in Pancreatic
Confirmed partial response in fourth-line metastatic pancreatic cancer patient, who had previously failed chemotherapy and checkpoint inhibitor therapy,...
United States Superkine Immunotherapies Merck Co Inc Medicenna Therapeutics Corp Merck Sharp Dohme Fahar Merchant
Source: globenewswire.com
DelveInsight Business Research LLP: Head and Neck Cancer Market to Surge at a CAGR of 5.1% by 2032
The head and neck cancer market is expected to show positive growth, mainly attributed to the increasing incident cases and the launch of upcoming therapies during the forecast period. Moreover
Source: finanznachrichten.de
Head and Neck Cancer Market to Surge at a CAGR of 5.1% by 2032
/PRNewswire/ -- DelveInsights Head and Neck Cancer Market Insights report includes a comprehensive understanding of current treatment practices, head and neck...
Source: prnewswire.com
Meet the 30 leading African startups in healthcare supply chains selected by Investing in Innovation (i3) for their new $7 million fund
Read the latest news across entertainment, sports, business and more. Be first to receive exclusive updates with your free subscription straight to your phone. - Pulse Ghana | Pulse Ghana
Source: pulse.com.gh
Adding Pembrolizumab to CRT Does Not Improve Outcomes in Head and Neck Cancer
Pembrolizumab plus chemoradiotherapy (CRT) appears no more effective than CRT alone in locally advanced head and neck squamous cell carcinoma.
Bruxelles Capitale Jean Pascal Machiels Cliniques Universitaires Saint Luc Merck Sharp Dohme Merck Sharp
Source: oncologynurseadvisor.com
Follow-Up Confirms DFS Benefit With Pembrolizumab in Clear Cell RCC
Adjuvant pembrolizumab could be a new standard of care for patients with clear cell RCC at increased risk of recurrence after nephrectomy.
Source: renalandurologynews.com
Global Hypolipidemics Market Drivers, Trends And Restraints For 2022-2031
The Business Research Company’s Hypolipidemics Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026
Source: einnews.com
30 African Healthcare Startups selected to join the Investing in Innovation Program
After the launch of the Investing in Innovation Program in June 2022, Southbridge A&I, Salient Advisory and SCIDaR have reached their second milestone by selecting 30 of the most promising African Health Tech companies. Join
Melinda Gates Foundation African Health Tech Impact Lab Innovation Program Salient Advisory Startup Bootcamp
Source: maurice-info.mu
Insights Into The Global Anemia And Other Blood Disorder Drugs Market 2022-2031 Forecast Period
The Business Research Company’s Anemia And Other Blood Disorder Drugs Global Market Report 2022: Market Size, Trends And Forecast To 2026
Source: einnews.com